Yue Hui Su
Director/Board Member at MAKALOT INDUSTRIAL CO., LTD.
Profile
Yue Hui Su is currently serving as an Independent Director at Makalot Industrial Co., Ltd., In Win Development, Inc., CECI Engineering Consultants, Inc., Ennoconn Corp., Formosa Pharmaceuticals, Inc., and Soochow University as a Professor in the Accounting Department.
Previously, Dr. Su held positions as an Independent Director at TWi Pharmaceuticals, Inc., a Member of the Supervisory Board at Bank of Kaohsiung Co., Ltd., and a Professor in the Accounting Department at Soochow University.
Dr. Su completed their undergraduate, graduate, and doctorate degrees at National Taiwan University.
Yue Hui Su active positions
| Companies | Position | Start |
|---|---|---|
| MAKALOT INDUSTRIAL CO., LTD. | Director/Board Member | 2011-02-20 |
| IN WIN DEVELOPMENT INC. | Director/Board Member | 2015-06-30 |
| ENNOCONN CORPORATION | Director/Board Member | - |
| FORMOSA PHARMACEUTICALS, INC. | Director/Board Member | 2021-07-08 |
| CECI Engineering Consultants, Inc. | Director/Board Member | - |
| Soochow University /Taiwan/ | Corporate Officer/Principal | - |
Former positions of Yue Hui Su
| Companies | Position | End |
|---|---|---|
| TWI PHARMACEUTICALS INC | Director/Board Member | - |
| Soochow University | Corporate Officer/Principal | - |
| BANK OF KAOHSIUNG CO., LTD. | Director/Board Member | - |
Training of Yue Hui Su
| National Taiwan University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| BANK OF KAOHSIUNG CO., LTD. | Finance |
| MAKALOT INDUSTRIAL CO., LTD. | Consumer Non-Durables |
| IN WIN DEVELOPMENT INC. | Electronic Technology |
| ENNOCONN CORPORATION | Electronic Technology |
| FORMOSA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| CECI Engineering Consultants, Inc. | |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Yue Hui Su
